InsidersTradesSigma
Explore the complete record of transactions filed by ANIDO ARMANDO, Chief Executive Officer. Officer active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 3 reports have been published. The latest transaction was disclosed on 17 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Armando Anido is the Chairman and CEO of Zynerba Pharmaceuticals, Inc. and SCYNEXIS Inc. He is responsible for the strategic direction of both companies, overseeing their operations and ensuring growth.